- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Choice Reaction Time.
Displaying page 1 of 2.
EudraCT Number: 2004-000235-28 | Sponsor Protocol Number: 190-060 | Start Date*: 2004-10-27 |
Sponsor Name:Sepracor Inc. | ||
Full Title: The effects of a single evening dose of 3mg eszopiclone on next day driving ability and psychomotor/memory function in patients with primary insomnia compared to placebo | ||
Medical condition: Insomnia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002073-26 | Sponsor Protocol Number: 1125-ECIR | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:Medical Center - University of Freiburg | |||||||||||||||||||||||
Full Title: Phase 1/2 Trial to determine the safety and efficacy of Extracorporeal photopheresis as treatment for steroid-refractory immune related adverse events after immune checkpoint inhibitor therapy | |||||||||||||||||||||||
Medical condition: Immune related adverse events induced by treatment with immune checkpoint inhibitors (monoclocanl antibodies against PD-1, PD-L1 or CTLA-4) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002405-47 | Sponsor Protocol Number: The CogNaive Study | Start Date*: 2007-07-31 |
Sponsor Name:Imperial College | ||
Full Title: A randomised prospective study assessing changes in neuro-cognitive function, using a computerised test battery, in treatment naïve HIV-1 positive subjects commencing two different antiretroviral r... | ||
Medical condition: HIV | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005307-42 | Sponsor Protocol Number: S2540345 | Start Date*: 2006-01-03 |
Sponsor Name:GlaxoSmithKline Consumer Healthcare | ||
Full Title: An evaluation of the 4 mg nicotine mint lozenge for the relief of cognitive impairment associated with nicotine withdrawal. | ||
Medical condition: Nicotine dependence. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-004008-16 | Sponsor Protocol Number: 20190172 | Start Date*: 2022-01-26 | |||||||||||
Sponsor Name:Amgen, Inc. | |||||||||||||
Full Title: A Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib and Panitumumab Versus Investigator’s Choice (Trifluridine and Tipiracil, or Regorafenib) for the Treatment of Pr... | |||||||||||||
Medical condition: Previously Treated Metastatic Colorectal Cancer Subjects with KRAS p.G12C Mutation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) DE (Restarted) GR (Ongoing) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001264-28 | Sponsor Protocol Number: P2-IMU-838-COV | Start Date*: 2020-05-28 | |||||||||||
Sponsor Name:Immunic AG | |||||||||||||
Full Title: A Prospective, Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Ca... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BG (Completed) RO (Completed) GR (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004553-72 | Sponsor Protocol Number: J2N-OX-JZNM(LOXO-BTK-20019) | Start Date*: 2021-07-14 | |||||||||||
Sponsor Name:Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company | |||||||||||||
Full Title: A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321) | |||||||||||||
Medical condition: Mantle cell lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) FR (Ongoing) AT (Ongoing) CZ (Ongoing) DE (Ongoing) PT (Ongoing) HU (Completed) NL (Ongoing) BE (Ongoing) IT (Ongoing) DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000230-34 | Sponsor Protocol Number: 15906A | Start Date*: 2014-09-23 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: An interventional, randomised, double-blind, parallel-group, placebo-controlled, active-referenced (paroxetine), fixed-dose study on the efficacy of vortioxetine on cognitive dysfunction in working... | |||||||||||||
Medical condition: Major depressive disorder and cognitive impairment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) FI (Completed) LT (Completed) DE (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000231-16 | Sponsor Protocol Number: 15907A | Start Date*: 2014-10-07 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: An interventional, randomised, double-blind, parallel-group, active-comparator, flexible-dose study on the efficacy of vortioxetine versus escitalopram on cognitive dysfunction in patients with ... | |||||||||||||
Medical condition: Major Depressive Disorder and cognitive impairment | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003984-37 | Sponsor Protocol Number: CMX001-211 | Start Date*: 2018-07-30 | |||||||||||
Sponsor Name:Chimerix, Inc | |||||||||||||
Full Title: A Randomized, Controlled, Open-Label, Multiple Ascending Dose Study of Intravenous Brincidofovir in Adult Allogeneic Hematopoietic Cell Transplant Recipients with Adenovirus Viremia | |||||||||||||
Medical condition: Treatment of adenovirus infections in adult allogeneic hematopoietic cell transplant recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003117-28 | Sponsor Protocol Number: EPU-P77 | Start Date*: 2014-11-03 | ||||||||||||||||
Sponsor Name: | ||||||||||||||||||
Full Title: Can Methylphenidate (Ritalin) improve memory and attention in mild cognitive impairment? An EEG study | ||||||||||||||||||
Medical condition: memory impairment in patients with Mild Cognitive Impairment | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000564-42 | Sponsor Protocol Number: CANNA-TICS | Start Date*: 2017-06-14 | ||||||||||||||||
Sponsor Name:Hannover Medical School | ||||||||||||||||||
Full Title: A randomized multi-centre double-blind placebo controlled trial to demonstrate the efficacy and safety of nabiximols in the treatment of adults with chronic tic disorders (CANNA-TICS) | ||||||||||||||||||
Medical condition: Chronic tic disorders and Tourette syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-017806-36 | Sponsor Protocol Number: CRC287 | Start Date*: 2010-11-03 | |||||||||||
Sponsor Name:University of Surrey | |||||||||||||
Full Title: Effect of Vitano® on physiological and psychological responses to psychological stress assessed under laboratory conditions and in everyday life. | |||||||||||||
Medical condition: Psychological stress | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000229-19 | Sponsor Protocol Number: 15905A | Start Date*: 2014-09-19 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: An interventional, randomised, double-blind, parallel-group, placebo-controlled study on the efficacy of vortioxetine on cognitive dysfunction in patients with partial or full remission of major de... | |||||||||||||
Medical condition: Major Depressive Disorder and cognitive impairment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) DE (Completed) FI (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002038-36 | Sponsor Protocol Number: 11018 | Start Date*: 2007-02-27 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with Parkinson’s disease dementia or dementia with Lewy Bodies | |||||||||||||
Medical condition: Patients with Parkinson’s disease dementia or dementia with Lewy Bodies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) GB (Completed) AT (Completed) IT (Completed) DE (Completed) FR (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004640-78 | Sponsor Protocol Number: ITI-007-004 | Start Date*: 2007-11-13 | |||||||||||
Sponsor Name:Intra-Cellular Therapies, Inc | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, 4-way crossover study of ITI-007 in subjects with sleep maintenance insomnia | |||||||||||||
Medical condition: Sleep maintenance disorders | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002971-18 | Sponsor Protocol Number: A00391 | Start Date*: 2005-04-29 | |||||||||||
Sponsor Name:UCB S.A. Pharma Sector | |||||||||||||
Full Title: A monocenter, double-blind, randomized trial, with two parallel groups comparing the clinical efficacy of levocetirizine 5 mg capsules and desloratadine 5 mg capsules taken once a day over 3 weeks ... | |||||||||||||
Medical condition: Adult subjects suffering from seasonal allergic rhinitis (SAR) due to grass pollen | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005742-37 | Sponsor Protocol Number: 06/AN/02 | Start Date*: 2007-01-26 | |||||||||||
Sponsor Name:NHS Glasgow and Clyde / University of Glasgow | |||||||||||||
Full Title: Randomised clinical trial of the effects of total intravenous anaesthesia (TIVA: propofol) versus volatile anaesthesia (sevoflurane-N20 induction and isoflurane-N20 maintenance) on children’s post... | |||||||||||||
Medical condition: Dental caries | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004244-37 | Sponsor Protocol Number: 13HH1824 | Start Date*: 2014-02-21 | |||||||||||
Sponsor Name:Imperial College London | Imperial College NHS Healthcare Trust | |||||||||||||
Full Title: The control of brain networks after traumatic brain injury: a neuroimaging and neuropsychological study of dopamine and cognition | |||||||||||||
Medical condition: Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001725-27 | Sponsor Protocol Number: KKSH152 | Start Date*: 2019-10-24 | |||||||||||
Sponsor Name:Martin-Luther-Universität Halle-Wittenberg | |||||||||||||
Full Title: A randomized, open, three-arm comparative study of modern methods of postoperative pain therapy in patients with knee endoprostheses. | |||||||||||||
Medical condition: Postoperative pain therapy after implantation of a knee endoprosthesis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.